Europeans are among those most sceptical of vaccine safety
Growing signs of public criticism risk slowing progress in reducing mortality
Add this topic to your myFT Digest for news straight to your inbox
You select the topic, we deliver the news.
Efficacy arguments delay new products. Plus Bangkok regional correspondent Michael Peel on the Mekong delta eradication campaign’s ‘race against time’